The global Hypersomnia Market is growing from USD 3.82 billion in 2025 to USD 5.98 billion by 2035 at a CAGR of 4.56% — a market whose growth reflects a long-overdue shift in how the medical community, patients, and pharmaceutical companies are approaching excessive daytime sleepiness as a clinically serious, treatable condition rather than a personal failing or lifestyle issue....